Literature DB >> 35747002

A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia.

Elrazi A Ali1, Mohammed A Alamin1, Mohammad Abu-Tineh2, Khalid Ahmed2, Awni Alshurafa2, Waail Rozi1, Mohamed A Yassin3.   

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory viral illness caused by coronavirus 2 (SARS-CoV-2). The disease often presents with non-specific symptoms, including fever, and fatigue, usually associated with respiratory symptoms (eg., cough) and other systemic involvement. The primary strategy to prevent transmission and reduce the disease severity of the SARS-CoV-2 infection is through vaccination. However, the virus had shown significant changes and mutations that resulted in the emergence of different strains. Each strain varies in its virulence, disease severity, and the body's immune system response. Previous reports showed that the Omicron variant causes mild disease. Little is known about the effect of Omicron in patients with acute leukemia. We present three patients with acute leukemia who had an infection with the Omicron variant of the SARS-CoV-2 virus.
Copyright © 2022, Ali et al.

Entities:  

Keywords:  acute leukemia; acute myeloid leukemia (aml); covid-19; omicron variant; sars-cov-2

Year:  2022        PMID: 35747002      PMCID: PMC9212524          DOI: 10.7759/cureus.25196

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

1.  COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.

Authors:  Lydia Scarfò; Thomas Chatzikonstantinou; Gian Matteo Rigolin; Giulia Quaresmini; Marina Motta; Candida Vitale; Jose Antonio Garcia-Marco; José Ángel Hernández-Rivas; Fatima Mirás; Mónica Baile; Juan Marquet; Carsten U Niemann; Gianluigi Reda; Talha Munir; Eva Gimeno; Monia Marchetti; Francesca Maria Quaglia; Marzia Varettoni; Julio Delgado; Sunil Iyengar; Ann Janssens; Roberto Marasca; Angela Ferrari; Carolina Cuéllar-García; Gilad Itchaki; Martin Špaček; Lorenzo De Paoli; Luca Laurenti; Mark-David Levin; Enrico Lista; Francesca R Mauro; Martin Šimkovič; Ellen Van Der Spek; Elisabeth Vandenberghe; Livio Trentin; Ewa Wasik-Szczepanek; Rosa Ruchlemer; Dominique Bron; Maria Rosaria De Paolis; Giovanni Del Poeta; Lucia Farina; Myriam Foglietta; Massimo Gentile; Yair Herishanu; Tobias Herold; Ozren Jaksic; Arnon P Kater; Sabina Kersting; Lara Malerba; Lorella Orsucci; Viola Maria Popov; Paolo Sportoletti; Mohamed Yassin; Barbara Pocali; Gabor Barna; Annalisa Chiarenza; Gimena Dos Santos; Eugene Nikitin; Martin Andres; Maria Dimou; Michael Doubek; Alicia Enrico; Yervand Hakobyan; Olga Kalashnikova; Macarena Ortiz Pareja; Maria Papaioannou; Davide Rossi; Nimish Shah; Amit Shrestha; Oana Stanca; Niki Stavroyianni; Vladimir Strugov; Constantine Tam; Mihnea Zdrenghea; Marta Coscia; Kostas Stamatopoulos; Giuseppe Rossi; Alessandro Rambaldi; Emili' Montserrat; Robin Foà; Antonio Cuneo; Paolo Ghia
Journal:  Leukemia       Date:  2020-07-09       Impact factor: 11.528

2.  Prevalence of Venous Thromboembolism in Critically Ill COVID-19 Patients: Systematic Review and Meta-Analysis.

Authors:  Mouhand F H Mohamed; Shaikha D Al-Shokri; Khaled M Shunnar; Sara F Mohamed; Mostafa S Najim; Shahd I Ibrahim; Hazem Elewa; Lina O Abdalla; Ahmed El-Bardissy; Mohamed Nabil Elshafei; Ibrahim Y Abubeker; Mohammed Danjuma; Khalid M Dousa; Mohamed A Yassin
Journal:  Front Cardiovasc Med       Date:  2021-01-08

3.  Prevalence, Clinical Manifestations, and Biochemical Data of Hypertensive versus Normotensive Symptomatic Patients with COVID-19: A Comparative Study.

Authors:  Vincenzo De Sanctis
Journal:  Acta Biomed       Date:  2020-11-10

4.  Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa.

Authors:  F Abdullah; J Myers; D Basu; G Tintinger; V Ueckermann; M Mathebula; R Ramlall; S Spoor; T de Villiers; Z Van der Walt; J Cloete; P Soma-Pillay; P Rheeder; F Paruk; A Engelbrecht; V Lalloo; M Myburg; J Kistan; W van Hougenhouck-Tulleken; M T Boswell; G Gray; R Welch; L Blumberg; W Jassat
Journal:  Int J Infect Dis       Date:  2021-12-28       Impact factor: 12.074

5.  SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.

Authors:  Elrazi A Ali; Ibrahim Khamees; Mohammad Abu-Tineh; Hana Qasim; Awni Alshurafa; Khalid Ahmed; Lujain Malkawi; Mohamed A Yassin
Journal:  Cureus       Date:  2022-04-05

6.  Increased risk of SARS-CoV-2 reinfection associated with emergence of Omicron in South Africa.

Authors:  Juliet R C Pulliam; Cari van Schalkwyk; Nevashan Govender; Anne von Gottberg; Cheryl Cohen; Michelle J Groome; Jonathan Dushoff; Koleka Mlisana; Harry Moultrie
Journal:  Science       Date:  2022-05-06       Impact factor: 63.714

Review 7.  Comorbidities and mortality rate in COVID-19 patients with hematological malignancies: A systematic review and meta-analysis.

Authors:  Adel Naimi; Ilya Yashmi; Reza Jebeleh; Mohammad Imani Mofrad; Shakiba Azimian Abhar; Yasaman Jannesar; Mohsen Heidary; Reza Pakzad
Journal:  J Clin Lab Anal       Date:  2022-04-06       Impact factor: 3.124

8.  SARS-CoV-2 and guttate psoriasis: A case report and review of literature.

Authors:  Elrazi Ali; Abdelaziz Mohamed; Joud Abuodeh; Mhd Kutaiba Albuni; Najlaa Al-Mannai; Sarah Salameh; Mahir Petkar; Elmukhtar Habas
Journal:  Clin Case Rep       Date:  2021-07-16

9.  Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.

Authors:  Elrazi Ali; Mohamed Badawi; Elabbass Abdelmahmuod; Samah Kohla; Mohamed A Yassin
Journal:  Am J Case Rep       Date:  2020-10-24

10.  Suboptimal Response to Coronavirus Disease 2019 Messenger RNA Vaccines in Patients With Hematologic Malignancies: A Need for Vigilance in the Postmasking Era.

Authors:  Mounzer E Agha; Maggie Blake; Charles Chilleo; Alan Wells; Ghady Haidar
Journal:  Open Forum Infect Dis       Date:  2021-06-30       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.